An MCNP-based model for the evaluation of the photoneutron dose in high energy medical electron accelerators.

The development of a computational model for the treatment head of a medical electron accelerator (Elekta/Philips SL-18) by the Monte Carlo code mcnp-4C2 is discussed. The model includes the major components of the accelerator head and a pmma phantom representing the patient body. Calculations were performed for a 14 MeV electron beam impinging on the accelerator target and a 10 cmx10 cm beam area at the isocentre. The model was used in order to predict the neutron ambient dose equivalent at the isocentre level and moreover the neutron absorbed dose distribution within the phantom. Calculations were validated against experimental measurements performed by gold foil activation detectors. The results of this study indicated that the equivalent dose at tissues or organs adjacent to the treatment field due to photoneutrons could be up to 10% of the total peripheral dose, for the specific accelerator characteristics examined. Therefore, photoneutrons should be taken into account when accurate dose calculations are required to sensitive tissues that are adjacent to the therapeutic X-ray beam. The method described can be extended to other accelerators and collimation configurations as well, upon specification of treatment head component dimensions, composition and nominal accelerating potential.

[1]  A. Torresin,et al.  Neutron measurements around medical electron accelerators by active and passive detection techniques. , 1991, Medical physics.

[2]  P Andreo,et al.  Calculation of absorbed dose and biological effectiveness from photonuclear reactions in a bremsstrahlung beam of end point 50 MeV. , 1999, Physics in medicine and biology.

[3]  C. Manfredotti,et al.  Evaluation of the Undesired Neutron Dose Equivalent to Critical Organs in Patients Treated by Linear Accelerator Gamma Ray Therapy , 1992 .

[4]  K W Burn,et al.  Analysis of photoneutron spectra produced in medical accelerators. , 2000, Physics in medicine and biology.

[5]  Icrp.  1990 Recommendations of the International Commission on Radiological Protection , 1991 .

[6]  R Nath,et al.  In-phantom dosimetry and spectrometry of photoneutrons from an 18 MV linear accelerator. , 1998, Medical physics.

[7]  R Mohan,et al.  Energy and angular distributions of photons from medical linear accelerators. , 1985, Medical physics.

[8]  W R Nelson,et al.  Unwanted photon and neutron radiation resulting from collimated photon beams interacting with the body of radiotherapy patients. , 1982, Medical physics.

[9]  S. Agosteo,et al.  Neutron fluxes in radiotherapy rooms. , 1993, Medical physics.

[10]  K. Kase,et al.  Neutron sources in the Varian Clinac 2100C/2300C medical accelerator calculated by the EGS4 code. , 1997, Health physics.

[11]  L Papiez,et al.  Contamination dose from photoneutron processes in bodily tissues during therapeutic radiation delivery. , 2003, Medical physics.

[12]  C J Evans,et al.  An MCNP-based model of a linear accelerator x-ray beam. , 1999, Physics in medicine and biology.

[13]  J J DeMarco,et al.  A CT-based Monte Carlo simulation tool for dosimetry planning and analysis. , 1998, Medical physics.

[14]  K W Burn,et al.  Monte Carlo simulation of the photoneutron field in linac radiotherapy treatments with different collimation systems , 2004, Physics in medicine and biology.

[15]  R. C. McCall,et al.  Room scattered neutrons. , 1999, Medical physics.

[16]  J. F. Briesmeister.  MCNP-A General Monte Carlo N-Particle Transport Code , 1993 .

[17]  I. Stamatelatos,et al.  Evaluation of neutron dose in the maze of medical electron accelerators. , 1999, Medical physics.

[18]  R. Nath,et al.  Depth dose-equivalent and effective energies of photoneutrons generated by 6-18 MV X-ray beams for radiotherapy. , 2001, Health physics.

[19]  D. J. Brenner.  Conversion Coefficients for Use in Radiological Protection against External Radiation , 1999 .